Evidence map›Paper›PMID 24838787›Full record

ArticleNeurology2014

Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.

Neil P Robertson, Neil J Scolding

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Pulsed immune reconstitution therapy in multiple sclerosis.Therapeutic advances in neurological disorders · 2019
    Review
  3. Review
  4. Review
  5. Alemtuzumab for Multiple Sclerosis.Current neurology and neuroscience reports · 2016
    Review
  6. Alemtuzumab for the treatment of multiple sclerosis.Therapeutics and clinical risk management · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Neil P RobertsonFrom the Department of Neurology (N.P.R.), Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales; and the Institute of Clinical Neurosciences (N.J.S.), University of Bristol, Frenchay Hospital, UK. robertsonnp@cf.ac.uk.
Neil J ScoldingFrom the Department of Neurology (N.P.R.), Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales; and the Institute of Clinical Neurosciences (N.J.S.), University of Bristol, Frenchay Hospital, UK.

Funding

Medical Research Council MR/K003771/1Medical Research Council MR/L010305/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleHumansImmunologic FactorsMaleMultiple SclerosisT-LymphocytesImmunologic Factors

Identifiers

PMID24838787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.